US Stock MarketDetailed Quotes

Relmada Therapeutics (RLMD)

Watchlist
  • 3.710
  • -0.090-2.37%
Trading Jan 16 14:17 ET
272.07MMarket Cap-2.08P/E (TTM)

Relmada Therapeutics (RLMD) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-74.34%13.89M
-70.73%20.62M
-67.64%27.06M
-53.38%44.91M
-53.38%44.91M
-49.07%54.12M
-40.57%70.44M
-36.87%83.61M
-35.06%96.32M
-35.06%96.32M
-Cash and cash equivalents
-6.69%1.38M
-35.13%1.35M
-13.88%1.15M
-5.73%3.86M
-5.73%3.86M
-77.85%1.48M
-85.58%2.09M
-95.38%1.34M
-24.17%4.09M
-24.17%4.09M
-Short-term investments
-76.25%12.5M
-71.81%19.27M
-68.51%25.91M
-55.49%41.05M
-55.49%41.05M
-47.14%52.63M
-34.32%68.35M
-20.54%82.28M
-35.47%92.23M
-35.47%92.23M
Prepaid assets
-38.94%967.75K
-11.70%474.63K
-20.73%596.41K
-25.20%886.46K
-25.20%886.46K
-44.08%1.58M
-84.53%537.52K
-75.65%752.33K
-70.63%1.19M
-70.63%1.19M
Total current assets
-73.33%14.85M
-70.28%21.09M
-67.22%27.66M
-53.03%45.8M
-53.03%45.8M
-48.94%55.7M
-41.83%70.97M
-37.75%84.37M
-36.21%97.51M
-36.21%97.51M
Non current assets
Other non current assets
0.00%21.98K
-59.02%21.98K
-49.04%21.98K
-49.04%21.98K
-49.04%21.98K
-53.95%21.98K
55.03%53.63K
23.66%43.13K
23.66%43.13K
23.66%43.13K
Total non current assets
0.00%21.98K
-59.02%21.98K
-49.04%21.98K
-49.04%21.98K
-49.04%21.98K
-53.95%21.98K
55.03%53.63K
23.66%43.13K
23.66%43.13K
23.66%43.13K
Total assets
-73.30%14.88M
-70.27%21.12M
-67.21%27.68M
-53.03%45.82M
-53.03%45.82M
-48.95%55.72M
-41.80%71.03M
-37.74%84.41M
-36.20%97.55M
-36.20%97.55M
Liabilities
Current liabilities
Payables
-38.05%1.45M
-67.38%1.36M
-75.62%1.27M
17.81%4.13M
17.81%4.13M
-17.89%2.35M
-13.99%4.17M
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
-accounts payable
-38.05%1.45M
-67.38%1.36M
-75.62%1.27M
17.81%4.13M
17.81%4.13M
-17.89%2.35M
-13.99%4.17M
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
Current accrued expenses
-58.34%1.82M
-48.76%2.23M
-54.63%2.95M
-11.92%5.01M
-11.92%5.01M
6.64%4.38M
-25.70%4.35M
14.45%6.5M
-8.10%5.68M
-8.10%5.68M
Other current liabilities
-120.00%-4
280.00%36
--11
400.00%27
400.00%27
158.82%20
---20
----
-121.95%-9
-121.95%-9
Current liabilities
-35.83%5.19M
-46.16%5.13M
-57.68%5.23M
-15.61%10.29M
-15.61%10.29M
-3.98%8.09M
-10.89%9.54M
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
Non current liabilities
Employee benefits
--221.11K
--32.12K
--7.51K
--4.47K
--4.47K
----
----
----
--0
--0
Other non current liabilities
----
----
----
----
----
--12.56K
----
----
----
----
Total non current liabilities
1,660.13%221.11K
--32.12K
--7.51K
--4.47K
--4.47K
--12.56K
--0
--0
--0
--0
Total liabilities
-33.20%5.41M
-45.82%5.17M
-57.62%5.24M
-15.57%10.3M
-15.57%10.3M
-3.83%8.1M
-10.89%9.54M
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
Shareholders'equity
Share capital
10.00%33.19K
10.00%33.19K
10.00%33.19K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.00%30.1K
0.00%30.1K
-common stock
10.00%33.19K
10.00%33.19K
10.00%33.19K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.00%30.1K
0.00%30.1K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-9.03%-678.4M
-11.29%-668.31M
-12.99%-658.44M
-14.26%-640.88M
-14.26%-640.88M
-16.14%-622.22M
-16.89%-600.5M
-19.31%-582.73M
-21.38%-560.9M
-21.38%-560.9M
Paid-in capital
2.69%687.83M
3.36%684.22M
3.99%680.85M
4.66%676.37M
4.66%676.37M
5.25%669.82M
5.91%661.96M
6.66%654.75M
7.26%646.23M
7.26%646.23M
Total stockholders'equity
-80.12%9.47M
-74.06%15.95M
-68.85%22.44M
-58.38%35.52M
-58.38%35.52M
-52.72%47.63M
-44.77%61.49M
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
Total equity
-80.12%9.47M
-74.06%15.95M
-68.85%22.44M
-58.38%35.52M
-58.38%35.52M
-52.72%47.63M
-44.77%61.49M
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -74.34%13.89M-70.73%20.62M-67.64%27.06M-53.38%44.91M-53.38%44.91M-49.07%54.12M-40.57%70.44M-36.87%83.61M-35.06%96.32M-35.06%96.32M
-Cash and cash equivalents -6.69%1.38M-35.13%1.35M-13.88%1.15M-5.73%3.86M-5.73%3.86M-77.85%1.48M-85.58%2.09M-95.38%1.34M-24.17%4.09M-24.17%4.09M
-Short-term investments -76.25%12.5M-71.81%19.27M-68.51%25.91M-55.49%41.05M-55.49%41.05M-47.14%52.63M-34.32%68.35M-20.54%82.28M-35.47%92.23M-35.47%92.23M
Prepaid assets -38.94%967.75K-11.70%474.63K-20.73%596.41K-25.20%886.46K-25.20%886.46K-44.08%1.58M-84.53%537.52K-75.65%752.33K-70.63%1.19M-70.63%1.19M
Total current assets -73.33%14.85M-70.28%21.09M-67.22%27.66M-53.03%45.8M-53.03%45.8M-48.94%55.7M-41.83%70.97M-37.75%84.37M-36.21%97.51M-36.21%97.51M
Non current assets
Other non current assets 0.00%21.98K-59.02%21.98K-49.04%21.98K-49.04%21.98K-49.04%21.98K-53.95%21.98K55.03%53.63K23.66%43.13K23.66%43.13K23.66%43.13K
Total non current assets 0.00%21.98K-59.02%21.98K-49.04%21.98K-49.04%21.98K-49.04%21.98K-53.95%21.98K55.03%53.63K23.66%43.13K23.66%43.13K23.66%43.13K
Total assets -73.30%14.88M-70.27%21.12M-67.21%27.68M-53.03%45.82M-53.03%45.82M-48.95%55.72M-41.80%71.03M-37.74%84.41M-36.20%97.55M-36.20%97.55M
Liabilities
Current liabilities
Payables -38.05%1.45M-67.38%1.36M-75.62%1.27M17.81%4.13M17.81%4.13M-17.89%2.35M-13.99%4.17M17.35%5.19M-33.37%3.51M-33.37%3.51M
-accounts payable -38.05%1.45M-67.38%1.36M-75.62%1.27M17.81%4.13M17.81%4.13M-17.89%2.35M-13.99%4.17M17.35%5.19M-33.37%3.51M-33.37%3.51M
Current accrued expenses -58.34%1.82M-48.76%2.23M-54.63%2.95M-11.92%5.01M-11.92%5.01M6.64%4.38M-25.70%4.35M14.45%6.5M-8.10%5.68M-8.10%5.68M
Other current liabilities -120.00%-4280.00%36--11400.00%27400.00%27158.82%20---20-----121.95%-9-121.95%-9
Current liabilities -35.83%5.19M-46.16%5.13M-57.68%5.23M-15.61%10.29M-15.61%10.29M-3.98%8.09M-10.89%9.54M22.43%12.36M-2.20%12.19M-2.20%12.19M
Non current liabilities
Employee benefits --221.11K--32.12K--7.51K--4.47K--4.47K--------------0--0
Other non current liabilities ----------------------12.56K----------------
Total non current liabilities 1,660.13%221.11K--32.12K--7.51K--4.47K--4.47K--12.56K--0--0--0--0
Total liabilities -33.20%5.41M-45.82%5.17M-57.62%5.24M-15.57%10.3M-15.57%10.3M-3.83%8.1M-10.89%9.54M22.43%12.36M-2.20%12.19M-2.20%12.19M
Shareholders'equity
Share capital 10.00%33.19K10.00%33.19K10.00%33.19K0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.00%30.1K0.00%30.1K
-common stock 10.00%33.19K10.00%33.19K10.00%33.19K0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.00%30.1K0.00%30.1K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -9.03%-678.4M-11.29%-668.31M-12.99%-658.44M-14.26%-640.88M-14.26%-640.88M-16.14%-622.22M-16.89%-600.5M-19.31%-582.73M-21.38%-560.9M-21.38%-560.9M
Paid-in capital 2.69%687.83M3.36%684.22M3.99%680.85M4.66%676.37M4.66%676.37M5.25%669.82M5.91%661.96M6.66%654.75M7.26%646.23M7.26%646.23M
Total stockholders'equity -80.12%9.47M-74.06%15.95M-68.85%22.44M-58.38%35.52M-58.38%35.52M-52.72%47.63M-44.77%61.49M-42.58%72.05M-39.22%85.36M-39.22%85.36M
Total equity -80.12%9.47M-74.06%15.95M-68.85%22.44M-58.38%35.52M-58.38%35.52M-52.72%47.63M-44.77%61.49M-42.58%72.05M-39.22%85.36M-39.22%85.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More